Orion Corp (OTCMKTS:ORINY) – Analysts at Jefferies Group increased their FY2017 EPS estimates for Orion in a research note issued to investors on Monday. Jefferies Group analyst J. Vane-Tempest now anticipates that the company will post earnings of $0.98 per share for the year, up from their prior forecast of $0.97. Jefferies Group also issued estimates for Orion’s FY2018 earnings at $0.98 EPS, FY2019 earnings at $0.97 EPS, FY2020 earnings at $0.93 EPS, FY2021 earnings at $0.94 EPS and FY2022 earnings at $1.03 EPS.

Separately, Zacks Investment Research lowered Orion from a “buy” rating to a “hold” rating in a research note on Tuesday, January 9th.

Orion (ORINY) opened at $15.65 on Wednesday. Orion has a 52-week low of $15.65 and a 52-week high of $21.17.

COPYRIGHT VIOLATION NOTICE: “Brokers Offer Predictions for Orion Corp’s FY2017 Earnings (ORINY)” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://www.thecerbatgem.com/2018/02/15/brokers-offer-predictions-for-orion-corps-fy2017-earnings-oriny.html.

About Orion

Orion Oyj engages in the development and manufacture of pharmaceuticals, active pharmaceutical ingredients (APIs), and diagnostic tests worldwide. The company operates in two segments, Pharmaceuticals and Diagnostics. The Pharmaceuticals segment develops, manufactures, and markets pharmaceuticals and APIs.

Receive News & Ratings for Orion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion and related companies with MarketBeat.com's FREE daily email newsletter.